Literature DB >> 10770209

Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.

A Sehested1, A A Juul, A M Andersson, J H Petersen, T K Jensen, J Müller, N E Skakkebaek.   

Abstract

Biochemical assessment of gonadal function during maturation in girls and in adult women can be troublesome. With the recent advent of specific assays for the gonadal peptides inhibin A and inhibin B, it might be possible to achieve a clearer picture of events. We therefore determined serum levels of inhibin A, inhibin B, FSH, LH and estradiol in a cross-sectional study of 403 healthy schoolgirls (aged 6 -20 yr) in relation to age and stage of puberty and in 181 healthy nonpregnant women (aged 20-32 yr) in relation to stage of the menstrual cycle. In addition, inhibin A and inhibin B were measured daily throughout the menstrual cycle in 10 healthy adult women. Levels of inhibin B are low or undetectable in prepubertal girls (median, 26.5 pg/mL; 95% prediction interval, <20-100 pg/mL), increase sharply through pubertal stage II to peak in stage III (median, 84 pg/mL; 95% prediction interval, 28-227 pg/mL) and thereafter decline through pubertal stages IV and V. These changes presumably reflect increasing ovarian stimulation through early puberty, resulting in an increased number of developing follicles, follicles reaching a later stage of development before undergoing atresia, or both. Declining levels in late puberty and adulthood probably reflect the onset of the menstrual cycle and the subsequent appearance of the luteal phase, where inhibin B levels are low. Inhibin A levels are undetectable or very low in early puberty (median, <7 pg/mL; 95% prediction interval, <7-14) pg/mL), increasing gradually through pubertal stages to reach their highest values in adult women (median, 21.5 pg/mL; 95% prediction interval, <7-129 pg/mL). Levels of inhibin A greater than 19 pg/mL are only seen in postmenarcheal girls in puberty and in adult women, again consistent with inhibin A being primarily produced by the corpus luteum. Determining cut-off levels of serum inhibin B regarding whether a girl had entered puberty resulted in similar (low) sensitivities and specificities as those found for cut-off levels of LH or estradiol due to the large overlap between serum values in Tanner stages I and II. Correlations between inhibin A and inhibin B and FSH, LH, and estradiol within pubertal stages are presented. In early puberty both inhibin A and inhibin B correlated positively with LH and FSH. In late puberty inhibin A correlated negatively with FSH and did not correlate with LH; inhibin B still correlated positively with both FSH and LH, now most strongly with FSH. In adult women during the menstrual cycle, serum inhibin B levels increased during the follicular phase, indicating the greatest production by follicles in early stages of development. In contrast, serum inhibin A levels peaked during the luteal phase, indicating the greatest production by the corpus luteum. In conclusion, serum inhibin A and inhibin B levels in normal puberty in girls show consistency with our knowledge of the manner in which these hormones are secreted within the menstrual cycle in adult women. The presented reference values may be of use in the clinical evaluation of pubertal development in girls.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770209     DOI: 10.1210/jcem.85.4.6512

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Intraindividual hormonal variability in ultrasonographically timed successive ovulatory menstrual cycles is detected only in the luteal phase in infertility patients.

Authors:  Kamal Ojha; Sophie C Barnes; Frances G Boa; Stephen Moody; Povilas Sladkevicius; Geeta Nargund; Paul O Collinson
Journal:  J Assist Reprod Genet       Date:  2002-08       Impact factor: 3.412

2.  Inhibin B and luteinizing hormone levels in girls aged 6-11 years from NHANES III, 1988-1994.

Authors:  Emily K Sims; O Y Addo; Audra L Gollenberg; John H Himes; Mary L Hediger; Peter A Lee
Journal:  Clin Endocrinol (Oxf)       Date:  2012-10       Impact factor: 3.478

Review 3.  Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.

Authors:  Ulrich Boehm; Pierre-Marc Bouloux; Mehul T Dattani; Nicolas de Roux; Catherine Dodé; Leo Dunkel; Andrew A Dwyer; Paolo Giacobini; Jean-Pierre Hardelin; Anders Juul; Mohamad Maghnie; Nelly Pitteloud; Vincent Prevot; Taneli Raivio; Manuel Tena-Sempere; Richard Quinton; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2015-07-21       Impact factor: 43.330

4.  Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency.

Authors:  A Biason-Lauber; E J Schoenle
Journal:  Am J Hum Genet       Date:  2000-10-18       Impact factor: 11.025

5.  Validity of Self-Assessed Sexual Maturation Against Physician Assessments and Hormone Levels.

Authors:  Jorge E Chavarro; Deborah J Watkins; Myriam C Afeiche; Zhenzhen Zhang; Brisa N Sánchez; David Cantonwine; Adriana Mercado-García; Clara Blank-Goldenberg; John D Meeker; Martha María Téllez-Rojo; Karen E Peterson
Journal:  J Pediatr       Date:  2017-04-21       Impact factor: 4.406

6.  Progesterone and bone: actions promoting bone health in women.

Authors:  Vanadin Seifert-Klauss; Jerilynn C Prior
Journal:  J Osteoporos       Date:  2010-10-31

Review 7.  Comparing Postnatal Development of Gonadal Hormones and Associated Social Behaviors in Rats, Mice, and Humans.

Authors:  Margaret R Bell
Journal:  Endocrinology       Date:  2018-07-01       Impact factor: 4.736

8.  Long-Term Follow-Up and Treatment of a Female With Complete Estrogen Insensitivity.

Authors:  Soumia Brakta; Lynn P Chorich; Hyung-Goo Kim; Laurel A Coons; John A Katzenellenbogen; Janet E Hall; Kenneth S Korach; Lawrence C Layman
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

9.  Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.

Authors:  Cathy E Elks; John R B Perry; Patrick Sulem; Daniel I Chasman; Nora Franceschini; Chunyan He; Kathryn L Lunetta; Jenny A Visser; Enda M Byrne; Diana L Cousminer; Daniel F Gudbjartsson; Tõnu Esko; Bjarke Feenstra; Jouke-Jan Hottenga; Daniel L Koller; Zoltán Kutalik; Peng Lin; Massimo Mangino; Mara Marongiu; Patrick F McArdle; Albert V Smith; Lisette Stolk; Sophie H van Wingerden; Jing Hua Zhao; Eva Albrecht; Tanguy Corre; Erik Ingelsson; Caroline Hayward; Patrik K E Magnusson; Erin N Smith; Shelia Ulivi; Nicole M Warrington; Lina Zgaga; Helen Alavere; Najaf Amin; Thor Aspelund; Stefania Bandinelli; Inês Barroso; Gerald S Berenson; Sven Bergmann; Hannah Blackburn; Eric Boerwinkle; Julie E Buring; Fabio Busonero; Harry Campbell; Stephen J Chanock; Wei Chen; Marilyn C Cornelis; David Couper; Andrea D Coviello; Pio d'Adamo; Ulf de Faire; Eco J C de Geus; Panos Deloukas; Angela Döring; George Davey Smith; Douglas F Easton; Gudny Eiriksdottir; Valur Emilsson; Johan Eriksson; Luigi Ferrucci; Aaron R Folsom; Tatiana Foroud; Melissa Garcia; Paolo Gasparini; Frank Geller; Christian Gieger; Vilmundur Gudnason; Per Hall; Susan E Hankinson; Liana Ferreli; Andrew C Heath; Dena G Hernandez; Albert Hofman; Frank B Hu; Thomas Illig; Marjo-Riitta Järvelin; Andrew D Johnson; David Karasik; Kay-Tee Khaw; Douglas P Kiel; Tuomas O Kilpeläinen; Ivana Kolcic; Peter Kraft; Lenore J Launer; Joop S E Laven; Shengxu Li; Jianjun Liu; Daniel Levy; Nicholas G Martin; Wendy L McArdle; Mads Melbye; Vincent Mooser; Jeffrey C Murray; Sarah S Murray; Michael A Nalls; Pau Navarro; Mari Nelis; Andrew R Ness; Kate Northstone; Ben A Oostra; Munro Peacock; Lyle J Palmer; Aarno Palotie; Guillaume Paré; Alex N Parker; Nancy L Pedersen; Leena Peltonen; Craig E Pennell; Paul Pharoah; Ozren Polasek; Andrew S Plump; Anneli Pouta; Eleonora Porcu; Thorunn Rafnar; John P Rice; Susan M Ring; Fernando Rivadeneira; Igor Rudan; Cinzia Sala; Veikko Salomaa; Serena Sanna; David Schlessinger; Nicholas J Schork; Angelo Scuteri; Ayellet V Segrè; Alan R Shuldiner; Nicole Soranzo; Ulla Sovio; Sathanur R Srinivasan; David P Strachan; Mar-Liis Tammesoo; Emmi Tikkanen; Daniela Toniolo; Kim Tsui; Laufey Tryggvadottir; Jonathon Tyrer; Manuela Uda; Rob M van Dam; Joyce B J van Meurs; Peter Vollenweider; Gerard Waeber; Nicholas J Wareham; Dawn M Waterworth; Michael N Weedon; H Erich Wichmann; Gonneke Willemsen; James F Wilson; Alan F Wright; Lauren Young; Guangju Zhai; Wei Vivian Zhuang; Laura J Bierut; Dorret I Boomsma; Heather A Boyd; Laura Crisponi; Ellen W Demerath; Cornelia M van Duijn; Michael J Econs; Tamara B Harris; David J Hunter; Ruth J F Loos; Andres Metspalu; Grant W Montgomery; Paul M Ridker; Tim D Spector; Elizabeth A Streeten; Kari Stefansson; Unnur Thorsteinsdottir; André G Uitterlinden; Elisabeth Widen; Joanne M Murabito; Ken K Ong; Anna Murray
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

10.  Serum inhibin B for differentiating between congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty: a systematic review and meta-analysis.

Authors:  Yuting Gao; Qin Du; Liyi Liu; Zhihong Liao
Journal:  Endocrine       Date:  2021-01-19       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.